Jun 18,2021 11:15 AM
Heavyweight Divis Lab was the top gainer by 0.23% at Rs4,312.20.
Stock market news that you should not miss today Jun 16,2021
|Resolution Type||Description Of Resolution||IiAS Recommendation|
|Name||LTP||PE||Mar Cap||NP Qtr||Div. Yld||Sales Qtr||BV|
|Sun Pharmaceuticals Industries Ltd||668.50||71.95||160,371.55||327.39||1.12||3,119.04||104.36|
|Divis Laboratories Ltd||4,197.30||56.94||111,305.67||487.93||0.48||1,718.39||349.25|
|Dr Reddys Laboratories Ltd||5,283.90||40.21||87,906.42||311.50||0.47||3,313.50||1,020.99|
|Cadila Healthcare Ltd||620.40||38.96||63,492.52||464.70||0.56||1,949.70||124.49|
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally. The company is a significant player in the Cardiovascular, Diabetology, Asthma, Pediatric, CNS, GI, Anti-Infective and NSAID space and holds global leadership position in the Anti-TB segment.Lupin Ltd was incorporated in th... More
Reports by lupin-ltd-share-price
Jun 19, 2021 12:16 PM
The company’s consolidated revenue stood at Rs4,504.87cr, up 13.31% yoy and 15.78% qoq.
12 May 2021
03 May 2021
28 Jan 2021
12 Jan 2021
04 Nov 2020
20 Oct 2020